Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| ARGENX | 3 | 10 | -0,34 % | ||
 | UCB | 3 | - | -0,12 % | |
| AB INBEV | 1 | 30 | +0,09 % | |
| LOTUS BAKERIES | 1 | - | +0,95 % | |
| AZELIS GROUP | 1 | - | -0,36 % | |
| MELEXIS | - | 4 | -0,26 % | |
| ELIA GROUP | - | 4 | -0,30 % | |
| UMICORE | - | 2 | -0,33 % | |
| AGEAS | - | 1 | 0,00 % | |
| KBC GROEP NV | - | 1 | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Oppenheimer hebt argenx-Kursziel wegen Umsatzwachstums auf 1.060 US-Dollar an | 7 | Investing.com Deutsch | ||
| Fr | Oppenheimer raises argenx stock price target to $1,060 on sales growth | 2 | Investing.com | ||
| Fr | Life beyond beer: Anheuser-Busch adds BeatBox to its portfolio, hits 5-year share price high | 7 | Seeking Alpha | ||
| Fr | LOTUS BAKERIES: Change of total number of voting rights | 2 | Euronext | ||
| Fr | UCB's fast-growing Bimzelx leaps across blockbuster sales threshold as HS momentum builds | 1 | FiercePharma | ||
| Fr | UCB FY 2025 slides: revenue surges 32%, BIMZELX drives growth | 6 | Investing.com | ||
| Fr | EQT exits remaining stake in Azelis Group | 256 | PR Newswire | EQT completes final selldown in Azelis Group NV, a leading global innovation service provider for the specialty chemicals and food ingredients industryUnder EQT's ownership, Azelis has delivered... ► Artikel lesen | |
| Fr | UCB übertrifft Prognosen im zweiten Halbjahr 2025 - Aktie legt zu | 4 | Investing.com Deutsch | ||
| Fr | These Analysts Revise Their Forecasts On Argenx After Q4 Earnings | 3 | Benzinga.com | ||
| Fr | Citizens raises argenx stock price target on ocular MG results | 4 | Investing.com | ||
| Fr | DEUTSCHE BANK RESEARCH stuft Argenx auf 'Hold' | 348 | dpa-AFX-Analyser | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Argenx auf "Hold" mit einem Kursziel von 675 Euro belassen. Das operative Ergebnis habe die Erwartungen verfehlt, schrieb... ► Artikel lesen | |
| Fr | Syensqo SA: Syensqo exercises the make-whole option to early redeem €500 million senior Bonds | 377 | GlobeNewswire (Europe) | Press release
Regulated information
Syensqo exercises the make-whole option to early redeem €500 million senior Bonds
Brussels, February 27, 2026 - 8:30 CET
Syensqo SA (the "Issuer")... ► Artikel lesen | |
| Fr | Ackermans & van Haaren ends a successful year 2025 with a net profit of 593 million euros (+29%) | 3 | GlobeNewswire (USA) | ||
| Do | BofA raises argenx stock price target to $1,013 on trial success | 7 | Investing.com | ||
| Do | OMG-argenx scores again with Vyvgart in ocular myasthenia gravis | 4 | FiercePharma | ||
| Do | Stifel cuts argenx stock price target to $1,227 on valuation | 6 | Investing.com | ||
| Do | Umicore - Transparency notification by Groupe Bruxelles Lambert S.A. | 7 | GlobeNewswire (USA) | ||
| Do | Umicore - Transparency notification by Bank of America Corporation | 9 | GlobeNewswire (USA) | ||
| Do | Umicore - Transparency notification by Barclays PLC | 12 | GlobeNewswire (USA) | ||
| Do | argenx Q4 2025 slides: first profitable year, 90% revenue surge | 4 | Investing.com |
1 2 3 4 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.